Pharmather Holdings Ltd PHRRF

@ the Bell: TSX powers through to close week higher

[TheLandedEagles]

Sorry my error...warrants are showing to be 16.8mm out at a exercise price of .80 cents...this could bring in potential cash funds of $13.4mm...NOT the $6mm indicated. See web "presentation"

[Jonathon Brown]

Canada’s main stock index inched up on Friday. The only drag on the TSX was a drop in the energy sector while mining led gains. read article.

[Jonathon Brown]

While energy gains propel the TSX, industrials get attention from the EV market and investors navigate another week of mining sector activity. read article.

[PressRelease]

TORONTO, May 01, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, announced today Sairiyo Therapeutics Inc. (“Sairiyo”), a company that is forty-nine percent (49%) owned by PharmaTher and fifty-one...read article.

[TheLandedEagles]

Glloyd...respectfully, go look at last recent public releases.. will provide you the info you need !!!!!

[Glloyd]

I thought the FDA was supposed to be approved today the 29th. Any ideas why it hasn't been and there's no update or anything?

[Itistoo]

They are actually closer to 2 mil in the bank right now, so they really need to get this approval sooner than later.  Just as important as that they need to have clients and sales lined up. If

[TheLandedEagles]

Investors looking for Big Rewards with minimal risk at this late stage of a FDA imminent approval,...needs to have a locked-in share position in PharmaTher....Hugh upside very soon. Look to the

[TheLandedEagles]

For sure...thats how I see things here for PHRM. Short and long term, this company will be huge in valuation. Time will only tell of coarse. Thats why I'm in and accumulating a very large position

[BradlTheGerman]

The article describes very well that ketamine can help in many areas of medicine, but that this fails due to regulations, among other things.   If the FDA grants approval, which I assume it

[BradlTheGerman]

Why low-cost ketamine is still inaccessible to many with severe depression A case study on ketamine reveals systemic barriers that prevent repurposing existing low-cost drugs like ketamine for

[TheLandedEagles]

Well...only God knows!!!...I dont give price predictions. Do know, in my opinion...PHRM, is drastically under valued today with its market valuation and with the anticipated near term probable FDA

[Sailormark]

How high will it go?

[TheLandedEagles]

Shortly we hear of FDA APPROVAL,..and suspect other great news announced of partnership with PHARMA's.  This company at this point has been de-risked, and highly probable of approval of

[TheLandedEagles]

HOW HIGH DO WE GO ON FDA  APPROVAL??...FDA approval is a reality and just around the corner. This company is worth a hell of a lot more than today..PHRM, has a extremely low share count..only

[Sailormark]

Yes. And when FDA approved I think $1-2-3-4 plus will come quickly. 

[Itistoo]

Theres the delay im sure most of us were expecting with the wording and deficiencies. Good news is that their are no further deficiencies, im sure a new goal date will come soon, hopefully not to far